胃口及其调节:心力衰竭有可口味的干预措施吗?
Matthew M Y Lee1, Michael E J Lean2, Naveed Sattar3
1School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK. Matthew.Lee.2@glasgow.ac.uk.
Current heart failure reports
|December 22, 2023
概括
减肥干预措施,包括新的药物,在治疗心力衰竭 (HF) 方面表现有前途. 有效的体重管理可以改善健康状况,并可能减少HF驱动器,补充现有的治疗方法.
科学领域:
- 心脏病学 心脏病学
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 肥胖是心力衰竭 (HF) 发生率和进展的重要危险因素.
- 调节食欲和限制饮食能量是体重管理的关键策略.
研究的目的:
- 审查心力衰竭患者对食欲调节和饮食能量限制的随机临床试验.
- 评估减肥干预措施对HF病理生理学和临床结果的影响.
主要方法:
- 报告和正在进行的随机临床试验的摘要.
- 对包括饮食计划,药物 (例如GLP-1受体激动剂) 和手术在内的干预措施的分析.
- 对健康状况改善和减肥效果数据的审查.
主要成果:
- 新型药物,如葡萄糖类-1受体激活剂,促进了相当大的体重减轻,与手术相比.
- 该STEP-HFpEF试验显示了健康状况的显著改善 (堪萨斯市心肌病问卷).
- 有效的体重管理可以缓解高频的关键驱动因素.
结论:
- 减肥干预措施为现有HF治疗提供了一个有希望的补充方法.
- 需要进一步的试验来证实体重减轻对HF患者临床事件的影响.
- 未来的研究应该专注于长期结果和药物治疗在HF管理中的作用.
相关概念视频
Regulation of Food Intake
239
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
239
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Heart Failure Drugs: Diuretics
394
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
394
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594
Taste Buds and Receptors
2.0K
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
2.0K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K


